Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDivestmentsFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Cresco Labs (CRLBF) Change in Receivables (2020 - 2026)

Cresco Labs filings provide 7 years of Change in Receivables readings, the most recent being -$406000.0 for Q1 2026.

  • On a quarterly basis, Change in Receivables fell 105.96% to -$406000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was -$19.2 million, a 392.58% decrease, with the full-year FY2025 number at -$12.0 million, down 795.32% from a year prior.
  • Change in Receivables hit -$406000.0 in Q1 2026 for Cresco Labs, up from -$20.9 million in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $14.2 million in Q4 2023 to a low of -$20.9 million in Q4 2025.
  • Median Change in Receivables over the past 5 years was -$1.4 million (2024), compared with a mean of -$1.2 million.
  • Biggest five-year swings in Change in Receivables: surged 380.0% in 2023 and later crashed 472.32% in 2025.
  • Cresco Labs' Change in Receivables stood at -$5.1 million in 2022, then surged by 380.0% to $14.2 million in 2023, then crashed by 60.45% to $5.6 million in 2024, then crashed by 472.32% to -$20.9 million in 2025, then skyrocketed by 98.06% to -$406000.0 in 2026.
  • The last three reported values for Change in Receivables were -$406000.0 (Q1 2026), -$20.9 million (Q4 2025), and -$3.7 million (Q3 2025) per Business Quant data.